ConductScience.org, home

Paper41909487

Neurovascular dysfunction in the development and progression of neuroinflammatory diseases.

Gowdy J and 3 others. Front Cell Neurosci, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Neurovascular dysfunction in the development and progression of neuroinflammatory diseases. Papers, record 41909487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41909487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neurovascular dysfunction in the development and progression of neuroinflammatory diseases.
PubMed
Journal
Front Cell Neurosci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gowdy JJamila
2Ahn JJulie
3Miller RHRobert H
4Islam YYusra

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References219

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128069965Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28069965PubMed
225784858Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.Front Cell Neurosci2015https://conductscience.org/library/papers/25784858PubMed
320012068Astrocytes: biology and pathology.Acta Neuropathol2010https://conductscience.org/library/papers/20012068PubMed
429443965A molecular atlas of cell types and zonation in the brain vasculature.Nature2018https://conductscience.org/library/papers/29443965PubMed
516443056Tetracyclines: nonantibiotic properties and their clinical implications.J Am Acad Dermatol2006https://conductscience.org/library/papers/16443056PubMed
636751789Neurovascular unit permeability in neuroinflammatory diseases: a common pathologic and therapeutic target?Neural Regen Res2023https://conductscience.org/library/papers/36751789PubMed
725611508Blood-brain barrier breakdown in the aging human hippocampus.Neuron2015https://conductscience.org/library/papers/25611508PubMed
821710622Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.Ann Neurol2011https://conductscience.org/library/papers/21710622PubMed
936893823An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity.Pharmacol Res2023https://conductscience.org/library/papers/36893823PubMed
1036736923How does neurovascular unit dysfunction contribute to multiple sclerosis?Neurobiol Dis2023https://conductscience.org/library/papers/36736923PubMed
1120164257Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions.Mol Biol Cell2010https://conductscience.org/library/papers/20164257PubMed
1225757756Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.J Cereb Blood Flow Metab2016https://conductscience.org/library/papers/25757756PubMed
1330699952Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage.Int J Mol Sci2019https://conductscience.org/library/papers/30699952PubMed
1429786072MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.Cell Death Differ2019https://conductscience.org/library/papers/29786072PubMed
1524946075The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Brain Pathol2014https://conductscience.org/library/papers/24946075PubMed
1636038917Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study.J Neuroinflammation2022https://conductscience.org/library/papers/36038917PubMed
1734445097Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment.Int J Mol Sci2021https://conductscience.org/library/papers/34445097PubMed
1837839276Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease.Parkinsonism Relat Disord2023https://conductscience.org/library/papers/37839276PubMed
1924170856C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24170856PubMed
2019829367Neuroscience: Alzheimer's disease.Nature2009https://conductscience.org/library/papers/19829367PubMed

See all 219 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42763304An integrated investigation of systemic and localized pathophysiological mechanisms of stroke and multimodal therapeutic strategies.Zhong Nan Da Xue Xue Bao Yi Xue Ban2026https://conductscience.org/library/papers/42763304PubMed
42653169Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging.Int J Mol Sci2026https://conductscience.org/library/papers/42653169PubMed
42558964Polysaccharide-rich birch sap attenuates kainic acid-induced acute seizures by suppressing TLR4/NF-κB-mediated inflammation and preserving blood-brain barrier and glutamate homeostasis.Front Pharmacol2026https://conductscience.org/library/papers/42558964PubMed
42120978Modeling blood-brain barrier-glioblastoma interactions: implications for chemoresistance and therapeutic targeting.Fluids Barriers CNS2026https://conductscience.org/library/papers/42120978PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41909487

GET https://conductscience.org/api/papers/v1/41909487/references?page=2